![](https://www.diabetesnews.com/wp-content/uploads/2017/12/iStock-515643880_small-150x150.jpg)
A recent study says that the access of people with type 2 diabetes to sodium-glucose cotransporter 2 (SGLT2) inhibitor treatment has significant ethnic, gender and socioeconomic disparities, with women, Black or Asian patients less likely to receive SGLT-2 inhibitor treatment. Read more